
    
      Lyrica is the trade name for pregabalin, which was first approved by the FDA in June 2005 and
      has been available through prescription since fall 2005, and is marketed by Pfizer. Lyrica is
      known to have clinical efficacy treating pain disorders including irritable bowel
      syndrome-related conditions such as fibromyalgia.
    
  